QUARKS - Lebensqualität und Resilienz bei KMT-Patienten Studie

Purpose:
Allogeneic stem cell transplantation (alloSCT) can be a very taxing treatment. Besides somatic factors, psychosocial variables need to be considered in order to optimize the benefit from this treatment for patients.

Methods:
This longitudinal study at the University Hospital Muenster, Germany, assesses the quality of life (QL), anxiety, depression and resilience in patients undergoing alloSCT at 3 time-points: beginning (T1) and end (T2) of inpatient treatment and 6 months after discharge (T3). The sample includes 65 patients (mainly leukemia, lymphoma, myeloma), aged 20-76 years. The instruments EORTC QLQ-C30, HADS, and Resilience Scale RS-25 are used. A semi-structured interview one year after alloSCT focuses on patients’ perception of their treatment.

Studienleitung:

PD Dr. Andrea Schumacher, Department of Medicine A / Hematology and Oncology

Beteiligte Wissenschaftler:

Dipl.-Math. C. Sauerland, Dr. rer. medic. R. Koch, Dipl.-Math.